USDA, FDA announce plan to split regulatory oversight of lab-grown meat

future food
Credit: Victor de Schwanberg/Science Photo Library

The Agriculture Department and FDA laid out new details on [November 16] about how the two agencies plan to split regulatory oversight over cell-based protein products — though it’s still possible Congress could amend those plans.

Under the proposed joint regulatory framework, FDA would oversee “cell collection, cell banks, and cell growth and differentiation,” according to a joint statement, and after that, the USDA will take over.

“USDA will then oversee the production and labeling of food products derived from the cells of livestock and poultry,” the statement added.

The agencies are still working out technical details of the framework. A public comment period will remain open through Dec. 26.


Related article:  CRISPR, lab-grown meat boost sustainable farming amid fears of biodiversity loss

Earlier this year, the debate over which arm of government would oversee the budding cell-cultured meat sector was seen as an interagency tug-of-war. Although Gottlieb and Perdue appear to largely be on the same page at this point, Congress might still tweak their roles.

Read full, original article: USDA, FDA agree how to divide regulatory turf on cell-based meats (Behind Paywall)

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend